Brazilian marine sponge Polymastia janeirensis induces apoptotic cell death in human U138MG glioma cell line, but not in a normal cell culture

被引:25
作者
Conte da Frota, Mario Luiz, Jr. [1 ,2 ]
Braganhol, Elizandra [3 ]
Canedo, Andres Delgado [4 ]
Klamt, Fabio [2 ]
Apel, Miriam Anders [5 ]
Mothes, Beatriz [6 ]
Lerner, Clea [6 ]
Oliveira Battastini, Ana Maria [3 ]
Henriques, Amelia Teresinha [5 ]
Fonseca Moreira, Jose Claudio [2 ]
机构
[1] Univ Fed Rio Grande do Sul, ICBS, Dept Bioquim, BR-90035003 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, ICBS, CEEO, BR-90035003 Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, ICBS, Lab Enzimol, BR-90035003 Porto Alegre, RS, Brazil
[4] IC FUC, Lab Cardiol Mol & Celular, Porto Alegre, RS, Brazil
[5] Univ Fed Rio Grande do Sul, Fac Farm, BR-90035003 Porto Alegre, RS, Brazil
[6] Museu Ciencias Nat, Fundacao Zoobot, Porto Alegre, RS, Brazil
关键词
Cancer; Glioma cells; Apoptosis; Marine sponges; Polymastia janeirensis; New drugs; OXIDATIVE STRESS; GLIOBLASTOMA-MULTIFORME; NATURAL-PRODUCTS; PHASE-II; TEMOZOLOMIDE; PATHWAYS; EXTRACTS; PHOSPHATIDYLSERINE; PHAGOCYTOSIS; METABOLITES;
D O I
10.1007/s10637-008-9134-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Marine sponges have been prominently featured in the area of cancer research. Here, we examined the anti-proliferative effects of crude extracts (aqueous and organic) of the Brazilian marine sponge Polymastia janeirensis in the U138MG human glioma cell line. Moreover, we examined the effects of extracts on selective cytotoxicity in the glioma cells in comparison with a normal cell culture. Exposure of glioma cells to treatments (24 h) resulted in cell number decrease at all doses tested, with both aqueous and organic extracts (IC50 < 20 and < 30 mu g/ml, respectively). Parallel to this result, sponge extracts reduced glioma cell viability (IC50 < 15 mu g/ml for both extracts). However, higher doses (50 and 100 mu g/ml) induced a stronger cytotoxic effect when compared to the lower dose tested (10 mu g/ml), inhibiting more than 80% of cellular growth and viability. Propidium iodide uptake and flow cytometry analysis further showed that sponge extracts caused necrosis in the glioma cell line at higher doses, while a high percentage of apoptotic glioma cells were observed at 10 mu g/ml. Moreover, apoptosis was prevented by the pan-caspase inhibitor Z-VAD, suggesting that marine sponge extracts, at lower doses, induce caspase-dependent apoptosis in U138MG glioma cells. Surprisingly the extracts herein tested were more effective than temozolomide, a potent inductor of apoptosis used for the treatment of malignant gliomas. Furthermore, our results suggested a selectivity cytotoxic effect on glioma cell line in comparison with a normal cell culture, since the effect on viability found in glioma cells was not observed in astrocyte cultures with the lower dose (10 mu g/ml). Thus, this marine sponge may be considered a good candidate for development of new cancer medicines with antitumor activity against gliomas.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 51 条
  • [41] Marine organisms and other novel natural sources of new cancer drugs
    Schwartsmann, G
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 235 - 243
  • [42] Oxidative stress interferes with cancer chemotherapy:: inhibition of lymphoma cell apoptosis and phagocytosis
    Shacter, E
    Williams, JA
    Hinson, RM
    Sentürker, S
    Lee, Y
    [J]. BLOOD, 2000, 96 (01) : 307 - 313
  • [43] Shacter E, 2002, ONCOLOGY-NY, V16, P217
  • [44] Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
    Stupp, R
    Dietrich, PY
    Kraljevic, SO
    Pica, A
    Maillard, I
    Maeder, P
    Meuli, R
    Janzer, R
    Pizzolato, G
    Miralbell, R
    Porchet, F
    Regli, L
    de Tribolet, N
    Mirimanoff, RO
    Leyvraz, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1375 - 1382
  • [45] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
    Stupp, R
    Mason, WP
    van den Bent, MJ
    Weller, M
    Fisher, B
    Taphoorn, MJB
    Belanger, K
    Brandes, AA
    Marosi, C
    Bogdahn, U
    Curschmann, J
    Janzer, RC
    Ludwin, SK
    Gorlia, T
    Allgeier, A
    Lacombe, D
    Cairncross, JG
    Eisenhauer, E
    Mirimanoff, RO
    Van Den Weyngaert, D
    Kaendler, S
    Krauseneck, P
    Vinolas, N
    Villa, S
    Wurm, RE
    Maillot, MHB
    Spagnolli, F
    Kantor, G
    Malhaire, JP
    Renard, L
    De Witte, O
    Scandolaro, L
    Vecht, CJ
    Maingon, P
    Lutterbach, J
    Kobierska, A
    Bolla, M
    Souchon, R
    Mitine, C
    Tzuk-Shina, T
    Kuten, A
    Haferkamp, G
    de Greve, J
    Priou, F
    Menten, J
    Rutten, I
    Clavere, P
    Malmstrom, A
    Jancar, B
    Newlands, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) : 987 - 996
  • [46] Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol
    terHaar, E
    Kowalski, RJ
    Hamel, E
    Lin, CM
    Longley, RE
    Gunasekera, SP
    Rosenkranz, HS
    Day, BW
    [J]. BIOCHEMISTRY, 1996, 35 (01) : 243 - 250
  • [47] SCREENING AND BIOASSAYS FOR BIOLOGICALLY-ACTIVE SUBSTANCES FROM 40 MARINE SPONGE SPECIES FROM SAN-DIEGO, CALIFORNIA, USA
    THOMPSON, JE
    WALKER, RP
    FAULKNER, DJ
    [J]. MARINE BIOLOGY, 1985, 88 (01) : 11 - 21
  • [48] The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review
    Wang, LG
    Liu, XM
    Kreis, W
    Budman, DR
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (05) : 355 - 361
  • [49] Yung, 1999, J CLIN ONCOL, V17, P3693
  • [50] Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse
    Yung, WKA
    Prados, MD
    Yaya-Tur, R
    Rosenfeld, SS
    Brada, M
    Friedman, HS
    Albright, R
    Olson, J
    Chang, SM
    O'Neill, AM
    Friedman, AH
    Bruner, J
    Yue, N
    Dugan, M
    Zaknoen, S
    Levin, VA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2762 - 2771